SOLVENTUM CORPORATION Capital Expenditures
SOLVENTUM CORPORATION (SOLV) reported Capital Expenditures of $167.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- SOLVENTUM CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $83.00M, a 24.55% decline year-over-year.
- SOLVENTUM CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $84.00M, a 22.94% decline year-over-year.
- SOLVENTUM CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $63.00M, a 50.39% decline year-over-year.
- SOLVENTUM CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $97.00M, a 4.30% increase year-over-year.
- SOLVENTUM CORPORATION payments to acquire property, plant, and equipment for fiscal 2025 was $379.00M, a 0.26% decline from fiscal 2024.
- SOLVENTUM CORPORATION payments to acquire property, plant, and equipment for fiscal 2024 was $380.00M, a 31.03% increase from fiscal 2023.
- SOLVENTUM CORPORATION payments to acquire property, plant, and equipment for fiscal 2023 was $290.00M, a 15.54% increase from fiscal 2022.
- SOLVENTUM CORPORATION payments to acquire property, plant, and equipment for fiscal 2022 was $251.00M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $83.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $167.00M 10-Q · filed 2026-08-05 | $230.00M derived: sum of 3 quarters · filed 2026-08-05 | $327.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $84.00M 10-Q · filed 2026-05-05 | $147.00M derived: sum of 2 quarters · filed 2026-05-05 | $244.00M derived: sum of 3 quarters · filed 2026-05-05 | $354.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $63.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $160.00M derived: sum of 2 quarters · filed 2026-02-27 | $270.00M derived: sum of 3 quarters · filed 2026-08-05 | $379.00M 10-K · filed 2026-02-27 |
| 2025-09-30 | $97.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $207.00M derived: sum of 2 quarters · filed 2026-08-05 | $316.00M 10-Q · filed 2025-11-06 | $443.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $110.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $219.00M 10-Q · filed 2026-08-05 | $346.00M derived: sum of 3 quarters · filed 2026-08-05 | $439.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $109.00M 10-Q · filed 2026-05-05 | $236.00M derived: sum of 2 quarters · filed 2026-05-05 | $329.00M derived: sum of 3 quarters · filed 2026-05-05 | $387.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $127.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $220.00M derived: sum of 2 quarters · filed 2026-02-27 | $278.00M derived: sum of 3 quarters · filed 2026-02-27 | $380.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $93.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $151.00M derived: sum of 2 quarters · filed 2025-11-06 | $253.00M 10-Q · filed 2025-11-06 | $341.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $58.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $160.00M 10-Q · filed 2025-08-08 | $248.00M derived: sum of 3 quarters · filed 2026-02-27 | $314.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $102.00M 10-Q · filed 2025-05-09 | $190.00M derived: sum of 2 quarters · filed 2026-02-27 | $256.00M derived: sum of 3 quarters · filed 2026-02-27 | $327.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $154.00M derived: sum of 2 quarters · filed 2026-02-27 | $225.00M derived: sum of 3 quarters · filed 2026-02-27 | $290.00M 10-K · filed 2026-02-27 |
| 2023-09-30 | $66.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $137.00M derived: sum of 2 quarters · filed 2024-11-08 | $202.00M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $71.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $136.00M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $65.00M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $251.00M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |